Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL

  • Jennifer A. Woyach
  • , Gabriela Perez Burbano
  • , Amy S. Ruppert
  • , Cecelia Miller
  • , Nyla A. Heerema
  • , Weiqiang Zhao
  • , Anna Wall
  • , Wei Ding
  • , Nancy L. Bartlett
  • , Danielle M. Brander
  • , Paul M. Barr
  • , Kerry A. Rogers
  • , Sameer A. Parikh
  • , Deborah M. Stephens
  • , Jennifer R. Brown
  • , Gerard Lozanski
  • , James Blachly
  • , Sreenivasa Nattam
  • , Richard A. Larson
  • , Harry Erba
    • Mark Litzow, Selina Luger, Carolyn Owen, Charles Kuzma, Jeremy S. Abramson, Richard F. Little, Shira Dinner, Richard M. Stone, Geoffrey Uy, Wendy Stock, Sumithra J. Mandrekar, John C. Byrd

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science